SARS-CoV-2 Spike Protein RBD (Omicron B.1.1.529 Variant) from ABBEXA LTD
Search, find, compare suppliers for SARS-CoV-2 Spike Protein RBD (Omicron B.1.1.529 Variant) products.
| Edit | |
|---|---|
| Product Name | SARS-CoV-2 Spike Protein RBD (Omicron B.1.1.529 Variant) |
| Description | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Protein Receptor-Binding Domain (RBD) is a recombinant protein expressed in Mammalian cells. The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the Spike Protein and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action. The B.1.1.529 (Omicron) variant was identified in South Africa in November 2021. It possess a large number of mutations (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H) which appear to increase the risk of reinfection compared to other variants of concern. N-terminal His tag. Purity > 90% (SDS-PAGE). Observed MW: 35 kDa |
| Size | 50 µg, 100 µg, 1 mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2, COVID-19, 2019-nCoV, 2019 novel coronavirus, COVID19, SARS-CoV-2 Spike S1 (RBD), SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, SARS-CoV-2 S1 Protein RBD (South Africa B.1.1.529 Variant), SARS-CoV-2 S1 Protein RBD (B.1.1.529 South Africa Variant), SARS-CoV-2 S1 Protein RBD (B.1.1.529 South African Variant), SARS-CoV-2 S1 Protein RBD (501Y.V2 South Africa Variant), SARS-CoV-2 S1 Protein RBD (501Y.V2 South African Variant), SARS-CoV-2 S1 Protein RBD (Omicron B.1.1.529 Variant), SARS-CoV-2 S1 Protein RBD (Omicron Variant), Severe Acute Respiratory Syndrome Coronavirus 2 protein, Protein Severe Acute Respiratory Syndrome Coronavirus 2, Virus Severe Acute Respiratory Syndrome Coronavirus 2 Protein, Virus Severe Acute Respiratory Syndrome Coronavirus 2, Virus protein Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2 protein, Protein SARS-CoV-2, Virus SARS-CoV-2 Protein, Virus SARS-CoV-2, Virus protein SARS-CoV-2, COVID-19 protein, Protein COVID-19, Virus COVID-19 Protein, Virus COVID-19, Virus protein COVID-19, 2019-nCoV protein, Protein 2019-nCoV, Virus 2019-nCoV Protein, Virus 2019-nCoV, Virus protein 2019-nCoV, 2019 novel coronavirus protein, Protein 2019 novel coronavirus, Virus 2019 novel coronavirus Protein, Virus 2019 novel coronavirus, Virus protein 2019 novel coronavirus, COVID19 protein, Protein COVID19, Virus COVID19 Protein, Virus COVID19, Virus protein COVID19, SARS-CoV-2 Spike S1 (RBD) protein, Protein SARS-CoV-2 Spike S1 (RBD), Virus SARS-CoV-2 Spike S1 (RBD) Protein, Virus SARS-CoV-2 Spike S1 (RBD), Virus protein SARS-CoV-2 Spike S1 (RBD), SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein protein, Protein SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, Virus SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein Protein, Virus SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, Virus protein SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, SARS-CoV-2 S1 Protein RBD (South Africa B.1.1.529 Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (South Africa B.1.1.529 Variant), Virus SARS-CoV-2 S1 Protein RBD (South Africa B.1.1.529 Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (South Africa B.1.1.529 Variant), Virus protein SARS-CoV-2 S1 Protein RBD (South Africa B.1.1.529 Variant), SARS-CoV-2 S1 Protein RBD (B.1.1.529 South Africa Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (B.1.1.529 South Africa Variant), Virus SARS-CoV-2 S1 Protein RBD (B.1.1.529 South Africa Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (B.1.1.529 South Africa Variant), Virus protein SARS-CoV-2 S1 Protein RBD (B.1.1.529 South Africa Variant), SARS-CoV-2 S1 Protein RBD (B.1.1.529 South African Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (B.1.1.529 South African Variant), Virus SARS-CoV-2 S1 Protein RBD (B.1.1.529 South African Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (B.1.1.529 South African Variant), Virus protein SARS-CoV-2 S1 Protein RBD (B.1.1.529 South African Variant), SARS-CoV-2 S1 Protein RBD (501Y.V2 South Africa Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (501Y.V2 South Africa Variant), Virus SARS-CoV-2 S1 Protein RBD (501Y.V2 South Africa Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (501Y.V2 South Africa Variant), Virus protein SARS-CoV-2 S1 Protein RBD (501Y.V2 South Africa Variant), SARS-CoV-2 S1 Protein RBD (501Y.V2 South African Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (501Y.V2 South African Variant), Virus SARS-CoV-2 S1 Protein RBD (501Y.V2 South African Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (501Y.V2 South African Variant), Virus protein SARS-CoV-2 S1 Protein RBD (501Y.V2 South African Variant), SARS-CoV-2 S1 Protein RBD (Omicron B.1.1.529 Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (Omicron B.1.1.529 Variant), Virus SARS-CoV-2 S1 Protein RBD (Omicron B.1.1.529 Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (Omicron B.1.1.529 Variant), Virus protein SARS-CoV-2 S1 Protein RBD (Omicron B.1.1.529 Variant), SARS-CoV-2 S1 Protein RBD (Omicron Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (Omicron Variant), Virus SARS-CoV-2 S1 Protein RBD (Omicron Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (Omicron Variant), Virus protein SARS-CoV-2 S1 Protein RBD (Omicron Variant) |
| Gene, Accession, CAS # | NCBI Accession: YP_009724390.1 |
| Catalog # | abx620026 |
| Price | please inquire |
| Order / More Info | SARS-CoV-2 Spike Protein RBD (Omicron B.1.1.529 Variant) from ABBEXA LTD |
| Product Specific References | n/a |
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950
Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com
https://www.abbexa.com
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950
Profile of ABBEXA LTD
Return to Products